Upadacitinib in Crohn's disease: needs more insight
A Tiwari - Expert Opinion on Pharmacotherapy, 2024 - Taylor & Francis
It has been very informative to go through the review article of Upadacitinib in Crohn's
disease by Dignass et al. The review has been comprehensive ranging right from the …
disease by Dignass et al. The review has been comprehensive ranging right from the …
[HTML][HTML] Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn's Disease: A Retrospective, Multicentre Study
B Farkas, T Bessissow, JK Limdi, K Sethi-Arora… - Journal of Clinical …, 2024 - mdpi.com
Background/Objectives: Data on the real-world effectiveness and safety of selective JAK
inhibitors (JAKis) in ulcerative colitis (UC) and Crohn's disease (CD) are limited. Methods …
inhibitors (JAKis) in ulcerative colitis (UC) and Crohn's disease (CD) are limited. Methods …
[HTML][HTML] Safety and Efficacy of Upadacitinib in Crohn's Disease: An Updated Systematic Review
AO Olatunji, M Maqbool, MA Abid, KS Makineni… - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Crohn's disease (CD) is a chronic inflammatory bowel disease that significantly impacts
patient quality of life. This systematic review evaluates the safety and efficacy of …
patient quality of life. This systematic review evaluates the safety and efficacy of …
[HTML][HTML] Small Molecule Therapy for Inflammatory Bowel Disease: JAK Inhibitors and S1PR Modulators
유경전， 혁윤 - The Korean Journal of Gastroenterology, 2024 - synapse.koreamed.org
Small molecules, including Janus kinase (JAK) inhibitors and sphingosine-1-phosphate
receptor modulators (S1PRMs), are promising new treatments for inflammatory bowel …
receptor modulators (S1PRMs), are promising new treatments for inflammatory bowel …
Drug-induced acne in inflammatory bowel disease: A practical guide for the gastroenterologist
MJ Temido, S Honap, AC Bursztejn… - Official journal of the …, 2022 - journals.lww.com
Drug-induced acne is a common side effect to a wide array of pharmacological therapies
and is characterized by a monomorphic, papulopustular eruption typically affecting the face …
and is characterized by a monomorphic, papulopustular eruption typically affecting the face …
PERSISTENCE, EFFECTIVENESS, AND SAFETY OF UPADACITINIB IN CROHN'S DISEASE AND ULCERATIVE COLITIS IN REAL LIFE: RESULTS FROM A …
MJ García, Y Brenes, M Vicuña, F Bermejo… - Official journal of the …, 2022 - journals.lww.com
Background: Real-world data on the effectiveness of upadacitinib for inflammatory bowel
disease (IBD) are limited. Aims: To assess upadacitinib persistence, effectiveness, and …
disease (IBD) are limited. Aims: To assess upadacitinib persistence, effectiveness, and …
[引用][C] 염증성장질환의소분자제제치료
전유경， 윤혁 - The Korean Journal of …, 2024 - Korean Society of Gastroenterology